Glucotrack, Inc.
GCTK- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001506983
No open-market purchases or sales by Glucotrack, Inc. insiders were filed in the last 90 days; 19 institutions reported holding it in 13F filings for Q2 2026, worth $187.1K in total; no superinvestor holds it.
Q2 2024 vs. Q1 2024
How the institutions holding Glucotrack, Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 7 | 3 | −4 |
| Shares | 784.7K | 29.9K | −754.8K (−96.2%) |
| Value | $272.9K | $60.2K | −$212.8K (−77.9%) |
New holders (2)
Institutions that held Glucotrack, Inc. at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Cetera Investment Advisers | 10,000 | $20.1K | 0.00% |
| UBS Group AG | 6,092 | $12.2K | 0.00% |
Sold out (6)
Institutions that held Glucotrack, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Sabby Management, LLC | 614,636 | $203.5K |
| Accurate Wealth Management, LLC | 22,098 | $18.1K |
| Virtue Capital Management, LLC | 30,000 | $12.6K |
| Citadel Advisors LLC | 22,024 | $7.27K |
| Susquehanna International Group, LLP | 13,684 | $4.52K |
| Renaissance Technologies LLC | 13,000 | $4.00K |